MAPT and Alzheimer disease: Hopeful attempts by AD researchers to establish visible biomarkers for tracing the real time course of Aβ and tau lesions in brain of living patients have followed a long, sometimes frustrating journey, as so far, histological findings at autopsy have usually suffered from technical limitations during the post-mortem procedure.